Via investment in research, in a microorganism multiplication lab, Norofert has come to secure most of raw materials it needs in production on its own.
Norofert had a turnover of RON21.04 million in the first half of 2024, up 4.27% compared to the same period of 2023, and a net profit of RON1.85 million, lower than the lebel reported in the same period in 2023, but above the budgeted level for the current year.
(English version by Catalina Apostoiu)